BRÈVE

sur Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)

CHEPLAPHARM Reorganizes Management Team

CHEPLAPHARM Group, headquartered in Greifswald, is restructuring its management team for future growth. As of 1 July 2024, Artem Gevorkyan has joined as Senior Vice President (SVP) Corporate Business Development. He previously worked at Sandoz and will be responsible for business development, mergers & acquisitions, and portfolio management.

Karl ‘Charly’ Lang will now lead the Supply Chain & Logistics division as Vice President (VP) across the entire CHEPLAPHARM Group. He assumes this role following Klaus Köhl, who is leaving the company at his own request.

Edeltraud Lafer, CEO of CHEPLAPHARM, expressed confidence in these appointments, stating that they are vital for the company’s future direction. She thanked Klaus Köhl for his contributions and wished him well.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Cheplapharm Arzneimittel GmbH